Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-19

Clinical Trial Update: Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study [Phase 3]

View source ↗

Summary

A Phase 3 follow-up study investigating intranasal oxytocin effects in alcohol withdrawal and dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intranasal oxytocin (oxytocin)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Alcoholism, Substance-Related Disorders | Phase 3 | Status: COMPLETED